Showing results (1211-1220 of 5,724) with videos related to

Sort By:
Pageof 573
Medical Oncology (Northwood, London, England)|December 17, 2024
Advancing miRNA cancer research through artificial intelligence: from biomarker discovery to therapeutic targetingRaghu Aswathy, Varghese Angel Chalos, Kanagaraj Suganya, et al.
Medical Oncology (Northwood, London, England)|February 11, 2025
Ethical and academic dilemmas in authorship of clinical research publications: a medical oncologist's perspectiveOzgur Tanriverdi
Medical Oncology (Northwood, London, England)|February 8, 2025
Chylothorax in thoracic oncology: diagnostic challenges and management strategiesLeonardo Duranti, Luca Tavecchio, Luigi Rolli, et al.
Medical Oncology (Northwood, London, England)|February 3, 2025
The anti-cancer activity of Dioscin: an update and future perspectiveMengYue Wang, YaNan Zhang, SongLin Ni, et al.
Medical Oncology (Northwood, London, England)|February 4, 2025
Carbon ion irradiation conquers the radioresistance by inducing complex DNA damage and apoptosis in U251 human glioblastomas cellsYulu Guo, Pingping Li, Jinhua Zhang, et al.
Medical Oncology (Northwood, London, England)|January 30, 2025
Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatmentAhmed I Abulsoud, Shaza H Aly, Sherif S Abdel Mageed, et al.
Medical Oncology (Northwood, London, England)|February 20, 2025
PHLPP1 depletion promotes tumorigenesis and stemness in triple-negative breast cancer cells through AKT signalingMd Anwarul Haque, Thanasis Poullikkas, F M Al-Amin Kaisar, et al.
Medical Oncology (Northwood, London, England)|February 23, 2025
Metal nanoparticles as a promising therapeutic approach for prostate cancer diagnosis and therapy: a comprehensive reviewMohamed J Saadh, Wajida Ataallah Khidr, Karar H Alfarttoosi, et al.
Medical Oncology (Northwood, London, England)|February 24, 2025
Characterization of lncRNAs contributing to drug resistance in epithelial ovarian cancerEhteram Khademi Siahestalkhi, Aydin Demiray, Arzu Yaren, et al.
Medical Oncology (Northwood, London, England)|January 21, 2025
Fusion of tumor cells and mesenchymal stem/stroma cells: a source of tumor heterogeneity, evolution and recurrenceZhen Liu, Yihao Wang, Zesheng Peng, et al.
Pageof 573